Please provide your email address to receive an email when new articles are posted on . Epstein-Barr virus activates certain B cells involved in systemic lupus erythematosus disease pathogenesis. The ...
A research team of Professor Yoontae Lee and Jiho Park, a PhD candidate, from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH) recently discovered that a ...
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to diagnose and evaluate people with systemic lupus erythematosus (SLE). The ...
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease driven by both genetic susceptibility and environmental risk factors. Epigenetic processes, which lie at the intersection of ...
Skin manifestations are common in patients with SLE. A recent study reported increased site-specific recurrence of cutaneous lupus erythematosus (CLE).1 While this study included a proportion of ...
A recent article in Cell Reports Medicine, by Dr. Felipe Andrade, uncovers insights into lupus symptoms. More specifically, how these symptoms can range in severity among individuals. Andrade is a ...
Among patients with new-onset systemic lupus erythematosus (SLE), 23% experienced one or more thromboembolic events (TEs). The incidence of TEs in antiphospholipid antibody-positive patients diagnosed ...
Clinical Trials Arena on MSN
SLE: Four trials to watch in 2026
As The European Lupus Society’s 15th annual soiree approaches, the Clinical Trials Arena team takes a look at four promising therapies in the SLE pipeline.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results